Related Experiment Video
Updated: Jun 10, 2026
09:07
In Vitro Model for Studying Differentiation and Changes of Multi-Omics on Murine Airway Epithelial Cells Stimulated with Cigarette Smoke Extract
Published on: July 12, 2024
Two-Stage Transformation Assay for Cigarette Smoke Condensates using Murine c3h-10t1/2 Fibroblasts
W K Schlage1, H Bülles, D Friedrichs
1INBIFO Institut für biologische Forschung, Fuggerstr. 3, 51149, Köln, Germany.
Summary
The two-stage transformation assay showed limited ability to quantitatively assess cigarette smoke condensate (CSC) promoter activity. While useful for qualitative analysis, it struggled to differentiate between CSC batches with varying in vivo tumorigenicity.
Area of Science:
- In vitro toxicology
- Carcinogenesis research
- Chemical carcinogenesis
Background:
- The two-stage transformation assay is a potential in vitro method to assess carcinogen promoter activity.
- Cigarette smoke condensate (CSC) is a complex mixture with known in vivo tumorigenicity.
- Standardization of in vitro assays is crucial for reliable toxicological assessments.
Purpose of the Study:
- To evaluate the applicability of the two-stage transformation assay for routine testing of CSC's promoter-like activity.
- To determine if the assay can serve as an in vitro alternative to in vivo mouse skin painting for CSC.
- To assess the assay's sensitivity and quantitative resolution for weak promoters like CSC.
Main Methods:
- Utilized a published two-stage transformation assay procedure with 3-methylcholanthrene (MCA) as the initiator.
- Employed rigorously standardized conditions including specific serum, subculture level, and preculturing.
- Assessed transformation by quantifying type II and type III foci, comparing CSC to positive control 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
Main Results:
- Transformation responses to CSC were lower compared to TPA.
- Variations in dose-response relationships prevented clear distinction between different CSC batches, even after extensive repetitions.
- Enhancement strategies, including increased treatment frequency and lowered initiator concentration, did not significantly improve CSC differentiation or signal-to-noise ratio.
Conclusions:
- The two-stage transformation assay is primarily suitable for qualitative assessment of weak promoter-like activity, such as that of CSC.
- The assay's quantitative resolution is insufficient for distinguishing between CSC batches with different in vivo tumorigenicity.
- Further refinement is needed to enhance the assay's sensitivity and reliability for quantitative toxicological comparisons of complex mixtures.
